Investigating genotype–phenotype relationships in Rett syndrome using an international data set

Background: Rett syndrome is an uncommon neurodevelopmental disorder with an incidence of 1:9,000 live female births. The principal genetic cause was first reported in 1999 when the association with mutations in the methyl-CpG-binding protein 2 (or MECP2) gene was identified. This study uses data from a large international database, InterRett, to examine genotype–phenotype relationships and compares these with previous findings in a population-based cohort. Method: The data set for these analyses was derived from a subset of InterRett cases with subject information collected from the family, the clinician, or both. Individual phenotypic characteristics and clinical severity using three scales were compared among those with eight known recurrent pathogenic MECP2 mutations as well as those with C-terminal deletions (n = 272). Results: Overall, p.R270X and p.R255X were the most severe and p.R133C and p.R294X were the mildest mutations. Significant differences by mutation were seen for individual phenotypic characteristics such as hand use, ambulation, and language. Conclusions: This multicenter investigation into the phenotypic correlates of MECP2 mutations in Rett syndrome has provided a greater depth of understanding than hitherto available about the specific phenotypic characteristics associated with commonly occurring mutations. Although the modifying influence of X inactivation on clinical severity could not be included in the analysis, the findings confirm clear genotype–phenotype relationships in Rett syndrome and show the benefits of collaboration crucial to effective research in rare disorders. GLOSSARY: ANOVA = analysis of variance; ARSD = Australian Rett Syndrome Database; IQR = interquartile range.

[1]  R. Fisher On the Interpretation of χ2 from Contingency Tables, and the Calculation of P , 2010 .

[2]  T. Charman,et al.  Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation , 2006, Journal of Medical Genetics.

[3]  Carol Bower,et al.  Rett syndrome in Australia: a review of the epidemiology. , 2006, The Journal of pediatrics.

[4]  R. Prescott,et al.  Predictive value of the early clinical signs in Rett disorder , 2005, Brain and Development.

[5]  R. Hastings,et al.  Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype–phenotype associations in Rett syndrome , 2005, European Journal of Human Genetics.

[6]  T. Matsuishi,et al.  Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms , 2005, Brain and Development.

[7]  H. Leonard,et al.  InterRett—The application of bioinformatics to International Rett syndrome research , 2005, Annals of human biology.

[8]  H. Smeets,et al.  Rett syndrome in females with CTS hot spot deletions: A disorder profile , 2005, American journal of medical genetics. Part A.

[9]  Linda Slack-Smith,et al.  How Can the Internet Help Parents of Children With Rare Neurologic Disorders? , 2004, Journal of child neurology.

[10]  R. Cantor,et al.  Phenotypic manifestations of MECP2 mutations in classical and atypical rett syndrome , 2004, American journal of medical genetics. Part A.

[11]  J Christodoulou,et al.  Refining the phenotype of common mutations in Rett syndrome , 2004, Journal of Medical Genetics.

[12]  H. Smeets,et al.  Rett syndrome in adolescent and adult females: Clinical and molecular genetic findings , 2003, American journal of medical genetics. Part A.

[13]  J. Christodoulou,et al.  InterRett and RettBASE: International Rett Syndrome Association Databases for Rett Syndrome , 2003, Journal of child neurology.

[14]  Andrew J. Grimm,et al.  RettBASE: The IRSA MECP2 variation database—a new mutation database in evolution , 2003, Human mutation.

[15]  T. Matsuishi,et al.  Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations? , 2003, Journal of medical genetics.

[16]  N. Laing,et al.  Effects of MECP2 mutation type, location and X‐inactivation in modulating Rett syndrome phenotype , 2003, American journal of medical genetics. Part A.

[17]  M. Msall,et al.  Describing the phenotype in Rett syndrome using a population database , 2003, Archives of disease in childhood.

[18]  F. Hanefeld,et al.  An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[19]  P. Huppke,et al.  Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. , 2002, Neuropediatrics.

[20]  E. Hoffman,et al.  Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. , 2002, Mental retardation and developmental disabilities research reviews.

[21]  E. Monrós,et al.  Rett syndrome in Spain: mutation analysis and clinical correlations , 2001, Brain and Development.

[22]  T. Matsuishi,et al.  Mutation analysis of the methyl-CpG-binding protein 2 gene (MECP2) in Rett patients with preserved speech , 2001, Brain and Development.

[23]  H. Leonard,et al.  Using the Internet to pilot a questionnaire on childhood disability in Rett syndrome. , 2001, Child: care, health and development.

[24]  Masaya Segawa,et al.  Guidelines for reporting clinical features in cases with MECP2 mutations , 2001, Brain and Development.

[25]  E. Hoffman,et al.  MeCP2 mutations in children with and without the phenotype of Rett syndrome , 2001, Neurology.

[26]  L. Peltonen,et al.  MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features , 2001, Neurology.

[27]  A. Silahtaroglu,et al.  MECP2 mutations in Danish patients with Rett syndrome: High frequency of mutations but no consistent correlations with clinical severity or with the X chromosome inactivation pattern , 2001, European Journal of Human Genetics.

[28]  H. Zoghbi,et al.  Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes , 2000, Annals of neurology.

[29]  D. Cooper,et al.  Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. , 2000, Human molecular genetics.

[30]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[31]  J. Christodoulou,et al.  A population‐based approach to the investigation of osteopenia in Rett syndrome , 1999, Developmental medicine and child neurology.

[32]  T. Perneger What's wrong with Bonferroni adjustments , 1998, BMJ.

[33]  B. Hagberg Clinical Delineation of Rett Syndrome Variants , 1995, Neuropediatrics.

[34]  Diagnostic criteria for rett syndrome , 1988 .

[35]  F. Yates Contingency Tables Involving Small Numbers and the χ2 Test , 1934 .

[36]  R. Fisher 036: On a Distribution Yielding the Error Functions of Several Well Known Statistics. , 1924 .

[37]  R. Fisher 019: On the Interpretation of x2 from Contingency Tables, and the Calculation of P. , 1922 .